Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Masahiko Nishiyama
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Living Beings
Chemicals & Drugs
Anatomy
Procedures
Physiology
Devices
Sign-in to see full Profile
Network (preview)
40
Toge, Tetsuya
22
Tanimoto, Keiji
17
Hiyama, Keiko
16
Kim, Ryungsa
12
Hiyama, Eiso
11
Kumazaki, Tsutomu
8
Yoshida, Kazuhiro
7
Yamamoto, Wataru
6
Aogi, Kenjiro
5
Hihara, Jun
5
Mitsui, Youji
5
Ukon, Kei
5
Noguchi, Tsuyoshi
5
Noguchi, Takuya
5
Ohtaki, Megu
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Masahiko Nishiyama (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Fumoto Shoichi; Tanimoto Keiji; Hiyama Eiso; Noguchi Tsuyoshi; Nishiyama Masahiko; Hiyama Keiko
EMP3 as a candidate tumor suppressor gene for solid tumors.
Expert opinion on therapeutic targets 2009;13(7):811-22.
-
2009: Fumoto Shoichi; Hiyama Keiko; Tanimoto Keiji; Noguchi Takuya; Hihara Jun; Hiyama Eiso; Noguchi Tsuyoshi; Nishiyama Masahiko
EMP3 as a tumor suppressor gene for esophageal squamous cell carcinoma.
Cancer letters 2009;274(1):25-32.
-
2008: Hiyama Keiko; Tanimoto Keiji; Nishimura Youhei; Tsugane Momomi; Fukuba Ikuko; Sotomaru Yusuke; Hiyama Eiso; Nishiyama Masahiko
Exploration of the genes responsible for unlimited proliferation of immortalized lung fibroblasts.
Experimental lung research 2008;34(7):373-90.
-
2008: Nakamura H; Tanimoto K; Hiyama K; Yunokawa M; Kawamoto T; Kato Y; Yoshiga K; Poellinger L; Hiyama E; Nishiyama M
Human mismatch repair gene, MLH1, is transcriptionally repressed by the hypoxia-inducible transcription factors, DEC1 and DEC2.
Oncogene 2008;27(30):4200-9.
-
2008: Fumoto Shoichi; Shimokuni Tatsushi; Tanimoto Keiji; Hiyama Keiko; Otani Keiko; Ohtaki Megu; Hihara Jun; Yoshida Kazuhiro; Hiyama Eiso; Noguchi Tsuyoshi; Nishiyama Masahiko
Selection of a novel drug-response predictor in esophageal cancer: a novel screening method using microarray and identification of IFITM1 as a potent marker gene of CDDP response.
International journal of oncology 2008;32(2):413-23.
-
2007: Arifin Marina; Hiyama Keiko; Tanimoto Keiji; Wiyono Wiwien Heru; Hiyama Eiso; Nishiyama Masahiko
EGFR activating aberration occurs independently of other genetic aberrations or telomerase activation in adenocarcinoma of the lung.
Oncology reports 2007;17(6):1405-11.
-
2007: Yunokawa Mayu; Tanimoto Keiji; Nakamura Hideaki; Nagai Nobutaka; Kudo Yoshiki; Kawamoto Takeshi; Kato Yukio; Hiyama Eiso; Hiyama Keiko; Nishiyama Masahiko
Differential regulation of DEC2 among hypoxia-inducible genes in endometrial carcinomas.
Oncology reports 2007;17(4):871-8.
-
2007: Tanimoto Keiji; Kaneyasu Mika; Shimokuni Tatsushi; Hiyama Keiko; Nishiyama Masahiko
Human carboxylesterase 1A2 expressed from carboxylesterase 1A1 and 1A2 genes is a potent predictor of CPT-11 cytotoxicity in vitro.
Pharmacogenetics and genomics 2007;17(1):1-10.
-
2006: Hiyama Eiso; Yamaoka Hiroaki; Kamimatsuse Arata; Onitake Yoshiyuki; Hiyama Keiko; Nishiyama Masahiko; Sueda Taijiro
Single nucleotide polymorphism array analysis to predict clinical outcome in neuroblastoma patients.
Journal of pediatric surgery 2006;41(12):2032-6.
-
2006: Yoshida Kazuhiro; Ninomiya Motoki; Takakura Norihisa; Hirabayashi Naoki; Takiyama Wataru; Sato Yuji; Todo Satoru; Terashima Masanori; Gotoh Mitsukazu; Sakamoto Jyunnichi; Nishiyama Masahiko
Phase II study of docetaxel and S-1 combination therapy for advanced or recurrent gastric cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(11 Pt 1):3402-7.
-
2006: Shimokuni Tatsushi; Tanimoto Keiji; Hiyama Keiko; Otani Keiko; Ohtaki Megu; Hihara Jun; Yoshida Kazuhiro; Noguchi Tsuyoshi; Kawahara Katsunobu; Natsugoe Shoji; Aikou Takashi; Okazaki Yasushi; Hayashizaki Yoshihide; Sato Yuji; Todo Satoru; Hiyama Eiso; Nishiyama Masahiko
Chemosensitivity prediction in esophageal squamous cell carcinoma: novel marker genes and efficacy-prediction formulae using their expression data.
International journal of oncology 2006;28(5):1153-62.
-
2006: Yasui Wataru; Ajani Jaffer A; Nishiyama Masahiko; Ohtsu Atsushi; Tahara Eiichi
Current progress of cancer chemotherapy The Fifteenth International Symposium of the Hiroshima Cancer Seminar, October 2005.
Cancer science 2006;97(4):328-31.
-
2006: Komatsu Masaaki; Hiyama Keiko; Tanimoto Keiji; Yunokawa Mayu; Otani Keiko; Ohtaki Megu; Hiyama Eiso; Kigawa Junzo; Ohwada Michitaka; Suzuki Mitsuaki; Nagai Nobutaka; Kudo Yoshiki; Nishiyama Masahiko
Prediction of individual response to platinum/paclitaxel combination using novel marker genes in ovarian cancers.
Molecular cancer therapeutics 2006;5(3):767-75.
-
2005: Nishiyama Masahiko
[Polygenetic pharmacogenomic strategies to identify drug sensitivity biomarkers]
Gan to kagaku ryoho. Cancer & chemotherapy 2005;32(12):1902-7.
-
2005: Hiyama Keiko; Otani Keiko; Ohtaki Megu; Satoh Kenichi; Kumazaki Tsutomu; Takahashi Tomoko; Mitsui Youji; Okazaki Yasushi; Hayashizaki Yoshihide; Omatsu Hideaki; Noguchi Takuya; Tanimoto Keiji; Nishiyama Masahiko
Differentially expressed genes throughout the cellular immortalization processes are quite different between normal human fibroblasts and endothelial cells.
International journal of oncology 2005;27(1):87-95.
-
2005: Nishiyama Masahiko
Cancer pharmacogenomics: progress and obstacles toward the goal.
International journal of clinical oncology / Japan Society of Clinical Oncology 2005;10(1):3-4.
-
2005: Ukon Kei; Tanimoto Keiji; Shimokuni Tatsushi; Noguchi Takuya; Hiyama Keiko; Tsujimoto Hiroaki; Fukushima Masakazu; Toge Tetsuya; Nishiyama Masahiko
Activator protein accelerates dihydropyrimidine dehydrogenase gene transcription in cancer cells.
Cancer research 2005;65(3):1055-62.
-
2004: Kuwai Toshio; Kitadai Yasuhiko; Tanaka Shinji; Kuroda Tsuyoshi; Ochiumi Takehiko; Matsumura Shunji; Oue Naohide; Yasui Wataru; Kaneyasu Mika; Tanimoto Keiji; Nishiyama Masahiko; Chayama Kazuaki
Single nucleotide polymorphism in the hypoxia-inducible factor-1alpha gene in colorectal carcinoma.
Oncology reports 2004;12(5):1033-7.
-
2004: Noguchi Takuya; Tanimoto Keiji; Shimokuni Tatsushi; Ukon Kei; Tsujimoto Hiroaki; Fukushima Masakazu; Noguchi Tsuyoshi; Kawahara Katsunobu; Hiyama Keiko; Nishiyama Masahiko
Aberrant methylation of DPYD promoter, DPYD expression, and cellular sensitivity to 5-fluorouracil in cancer cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(20):7100-7.
-
2004: Tanaka Tomotaka; Tanimoto Keiji; Otani Keiko; Satoh Kenichi; Ohtaki Megu; Yoshida Kazuhiro; Toge Tetsuya; Yahata Hiroshi; Tanaka Shinji; Chayama Kazuaki; Okazaki Yasushi; Hayashizaki Yoshihide; Hiyama Keiko; Nishiyama Masahiko
Concise prediction models of anticancer efficacy of 8 drugs using expression data from 12 selected genes.
International journal of cancer. Journal international du cancer 2004;111(4):617-26.
-
2004: Kumazaki Tsutomu; Hiyama Keiko; Takahashi Tomoko; Omatsu Hideaki; Tanimoto Keiji; Noguchi Takuya; Hiyama Eiso; Mitsui Youji; Nishiyama Masahiko
Differential gene expressions during immortalization of normal human fibroblasts and endothelial cells transfected with human telomerase reverse transcriptase gene.
International journal of oncology 2004;24(6):1435-42.
-
2004: Yoshida Kazuhiro; Hirabayashi Naoki; Takiyama Wataru; Ninomiya Motoki; Takakura Norihisa; Sakamoto Jyunnichi; Nishiyama Masahiko; Toge Tetsuya
Phase I study of combination therapy with S-1 and docetaxel (TXT) for advanced or recurrent gastric cancer.
Anticancer research 2004;24(3b):1843-51.
-
2003: Hiyama Eiso; Hiyama Keiko; Nishiyama Masahiko; Reynolds C Partrik; Shay Jerry W; Yokoyama Takashi
Differential gene expression profiles between neuroblastomas with high telomerase activity and low telomerase activity.
Journal of pediatric surgery 2003;38(12):1730-4.
-
2003: Tanimoto Keiji; Yoshiga Koji; Eguchi Hidetaka; Kaneyasu Mika; Ukon Kei; Kumazaki Tsutomu; Oue Naohide; Yasui Wataru; Imai Kazue; Nakachi Kei; Poellinger Lorenz; Nishiyama Masahiko
Hypoxia-inducible factor-1alpha polymorphisms associated with enhanced transactivation capacity, implying clinical significance.
Carcinogenesis 2003;24(11):1779-83.
-
2003: Kumazaki Tsutomu; Sasaki Masao; Nishiyama Masahiko; Teranishi Yasuhiro; Sumida Hiroshi; Eboshida Akira; Mitsui Youji
Life span shortening of normal fibroblasts by overexpression of BCL-2: a result of potent increase in cell death.
Experimental cell research 2003;285(2):299-308.
-
2003: Yasui Wataru; Nishiyama Masahiko; Tsuruo Takashi; Tahara Eiichi
Molecular targeting therapy for cancer: the Twelfth International Symposium of the Hiroshima Cancer Seminar, November 2002.
Cancer science 2003;94(2):221-3.
-
2003: Sasaki Masao; Kumazaki Tsutomu; Tanimoto Keiji; Nishiyama Masahiko
Bcl-2 in cancer and normal tissue cells as a prediction marker of response to 5-fluorouracil.
International journal of oncology 2003;22(1):181-6.
-
2003: Yoshida Kazuhiro; Tanabe Kazuaki; Ueno Hideaki; Ohta Kouji; Hihara Jun; Toge Tetsuya; Nishiyama Masahiko
Future prospects of personalized chemotherapy in gastric cancer patients: results of a prospective randomized pilot study.
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 2003;6 Suppl 1():82-9.
-
2002: Miyazaki Kazuko; Kawamoto Takeshi; Tanimoto Keiji; Nishiyama Masahiko; Honda Hiroaki; Kato Yukio
Identification of functional hypoxia response elements in the promoter region of the DEC1 and DEC2 genes.
The Journal of biological chemistry 2002;277(49):47014-21.
-
2002: Park Ji Seon; Yamamoto Wataru; Sekikawa Takashi; Matsukawa Masaaki; Okamoto Ryo; Sasaki Masao; Ukon Kei; Tanimoto Keiji; Kumazaki Tsutomu; Nishiyama Masahiko
Cellular sensitivity determinants to docetaxel in human gastrointestinal cancers.
International journal of oncology 2002;20(2):333-8.
-
2002: Okamoto Ryo; Takano Hiroshi; Okamura Tatsunori; Park Ji-Seon; Tanimoto Keiji; Sekikawa Takashi; Yamamoto Wataru; Sparreboom Alex; Verweij Jaap; Nishiyama Masahiko
O(6)-methylguanine-DNA methyltransferase (MGMT) as a determinant of resistance to camptothecin derivatives.
Japanese journal of cancer research : Gann 2002;93(1):93-102.
-
2002: Kumazaki Tsutomu; Sasaki Masao; Nishiyama Masahiko; Teranishi Yasuhiro; Sumida Hiroshi; Mitsui Youji
Effect of BCL-2 down-regulation on cellular life span.
Biogerontology 2002;3(5):291-300.
-
2001: Okamoto R; Takano H; Sekikawa T; Tanaka T; Toyada M; Ukon K; Tanimoto K; Kumazaki T; Nishiyama M
Unique action determinants of double acting topoisomerase inhibitor, TAS-103.
International journal of oncology 2001;19(5):921-7.
-
2001: Yoshida K; Nishimoto N; Kagawa Y; Hihara J; Inoue H; Kim R; Hirai T; Nishiyama M; Toge T
[A new therapeutic approach to advanced and recurrent gastric cancer by TS-1]
Gan to kagaku ryoho. Cancer & chemotherapy 2001;28(10):1403-12.
-
2001: Hayashi I; Nishiyama M
[Genome research and anticancer chemotherapy]
Gan to kagaku ryoho. Cancer & chemotherapy 2001;28(9):1183-9.
-
2000: Murakami S; Yoshida K; Kin R; Nishimoto N; Kagawa Y; Yano Y; Nishiyama M; Hirai T; Toge T
[The clinical effect of low-dose FP (5-FU + low-dose CDDP) in patients with far advanced gastric cancer, and their quality of life]
Gan to kagaku ryoho. Cancer & chemotherapy 2000;27(6):853-8.
-
2000: Toge T; Nakazato H; Nishiyama M; Hirata K; Yamamitsu S; Sowa M; Saji S
[Current status of "low-dose cisplatin-5-FU therapy" for solid tumors (2nd report)--from a nationwide questionnaire on its adverse effects]
Gan to kagaku ryoho. Cancer & chemotherapy 2000;27(4):549-58.
-
2000: Okamura T; Kurisu K; Yamamoto W; Takano H; Nishiyama M
NADPH/quinone oxidoreductase is a priority target of glioblastoma chemotherapy.
International journal of oncology 2000;16(2):295-303.
-
1999: Nishiyama M; Yamamoto W; Park J S; Okamoto R; Hanaoka H; Takano H; Saito N; Matsukawa M; Shirasaka T; Kurihara M
Low-dose cisplatin and 5-fluorouracil in combination can repress increased gene expression of cellular resistance determinants to themselves.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(9):2620-8.
-
1999: Suzuki K; Yamamoto W; Park J S; Hanaoka H; Okamoto R; Kirihara Y; Yorishima T; Okamura T; Kumazaki T; Nishiyama M
Regulatory network of mitomycin C action in human colon cancer cells.
Japanese journal of cancer research : Gann 1999;90(5):571-7.
-
1999: Kumazaki T; Mitsui Y; Hamada K; Sumida H; Nishiyama M
Detection of alternative splicing of fibronectin mRNA in a single cell.
Journal of cell science 1999;112 ( Pt 10)():1449-53.
-
1999: Kirihara Y; Yamamoto W; Toge T; Nishiyama M
Dihydropyrimidine dehydrogenase, multidrug resistance-associated protein, and thymidylate synthase gene expression levels can predict 5-fluorouracil resistance in human gastrointestinal cancer cells.
International journal of oncology 1999;14(3):551-6.
-
1997: Nishiyama M; Suzuki K; Kumazaki T; Yamamoto W; Toge T; Okamura T; Kurisu K
Molecular targeting of mitomycin C chemotherapy.
International journal of cancer. Journal international du cancer 1997;72(4):649-56.
-
1997: Aogi K; Nishiyama M; Kim R; Hirabayashi N; Toge T; Mizutani A; Okada K; Sumiyoshi H; Fujiwara Y; Yamakido M; Kusano T; Andoh T
Overcoming CPT-11 resistance by using a biscoclaurine alkaloid, cepharanthine, to modulate plasma trans-membrane potential.
International journal of cancer. Journal international du cancer 1997;72(2):295-300.
-
1997: Sakamoto N; Toge T; Nishiyama M
Tumor-specific synergistic therapy of mitomycin C: modulation of bioreductive activation.
Hiroshima journal of medical sciences 1997;46(2):67-73.
-
1997: Nishiyama M; Toge T
Selection of adjuvant chemotherapy for gastric cancer using objective criteria.
Gan to kagaku ryoho. Cancer & chemotherapy 1997;24 Suppl 1():232-8.
-
1995: Saeki S; Nishiyama M; Toge T
DT-diaphorase as a target enzyme for biochemical modulation of mitomycin C.
Hiroshima journal of medical sciences 1995;44(3):55-63.
-
1995: Yoshida K; Kawami H; Yamaguchi Y; Kuniyasu H; Nishiyama M; Hirai T; Yanagihara K; Tahara E; Toge T
Retrovirally transmitted gene therapy for gastric carcinoma using herpes simplex virus thymidine kinase gene.
Cancer 1995;75(6 Suppl):1467-71.
-
1995: Nishiyama M; Takashima I; Tanaka T; Yoshida K; Toge T; Nagata N; Iwamori S; Tamura Y
Carcinoembryonic antigen levels in the peritoneal cavity: useful guide to peritoneal recurrence and prognosis for gastric cancer.
World journal of surgery 1995;19(1):133-7; discussion 137.
-
1994: Nishida T; Tanaka S; Haruma K; Ohtsu N; Tsuda T; Yoshihara M; Sumii K; Kajiyama G; Nishiyama M; Hirai T
[The risk factors of lymph node metastasis in submucosal invasive gastric carcinoma--assessment of the indication for endoscopic treatment]
Nippon Shokakibyo Gakkai zasshi The Japanese journal of gastro-enterology 1994;91(9):1399-406.
-
1993: Kawami H; Yoshida K; Ohsaki A; Kuroi K; Nishiyama M; Toge T
Stromelysin-3 mRNA expression and malignancy: comparison with clinicopathological features and type IV collagenase mRNA expression in breast tumors.
Anticancer research 1993;13(6A):2319-23.
-
1993: Nishiyama M; Saeki S; Aogi K; Hirabayashi N; Toge T
[Mitomycin C and its bioreduction: relevance of NAD(P)H: quinone oxidoreductase activity to mitomycin C-induced DNA damage and cytotoxicity]
Gan to kagaku ryoho. Cancer & chemotherapy 1993;20(8):1037-41.
-
1993: Nishiyama M; Saeki S; Aogi K; Hirabayashi N; Toge T
Relevance of DT-diaphorase activity to mitomycin C (MMC) efficacy on human cancer cells: differences in in vitro and in vivo systems.
International journal of cancer. Journal international du cancer 1993;53(6):1013-6.
-
1992: Nishiyama M; Aogi K; Saeki S; Kim R; Kuroi K; Yamaguchi Y; Toge T
A role for plasma membrane potential in doxorubicin--induced cytotoxicity.
Anticancer research 1992;12(3):849-52.
-
1992: Kim R; Hirabayashi N; Nishiyama M; Jinushi K; Toge T; Okada K
Experimental studies on biochemical modulation targeting topoisomerase I and II in human tumor xenografts in nude mice.
International journal of cancer. Journal international du cancer 1992;50(5):760-6.
-
1992: Kim R; Hirabayashi N; Nishiyama M; Jinushi K; Toge T; Okada K
Factors contributing to adriamycin sensitivity in human xenograft tumors: the relationship between expression of the MDR1, GST-pi and topoisomerase II genes and tumor sensitivity to adriamycin.
Anticancer research 1992;12(1):241-5.
-
1991: Nishiyama M; Aogi K; Saeki S; Hirabayashi N; Toge T
[Combination of a biscoclaurine alkaloid, cepharanthine, and anticancer agents: effects and mechanism in human gastric and pancreatic carcinoma cell lines]
Gan to kagaku ryoho. Cancer & chemotherapy 1991;18(14):2429-33.
-
1991: Kim R; Hirabayashi N; Nishiyama M; Aogi K; Toge T
Clinical significance of P-glycoprotein expression analyzed by immunohistochemical staining in cancer tissues.
The Japanese journal of surgery 1991;21(5):590-3.
-
1991: Kim R; Hirabayashi N; Nishiyama M; Yorishima T; Toge T; Okada K
mRNA expression of topoisomerase II in human tumors and normal tissues.
The Japanese journal of surgery 1991;21(5):587-9.
-
1991: Kim R; Hirabayashi N; Nishiyama M; Saeki S; Toge T; Okada K
Expression of MDR1, GST-pi and topoisomerase II as an indicator of clinical response to adriamycin.
Anticancer research 1991;11(1):429-31.
-
1990: Jinushi K; Hirabayashi N; Kirihara Y; Takagami S; Ryuji K; Yorishima T; Nishiyama M; Noso Y; Toge T
[Clinical studies of in vitro chemosensitivity test evaluated by ATP assay of gastrointestinal cancer]
Gan to kagaku ryoho. Cancer & chemotherapy 1990;17(11):2235-9.
-
1990: Kim R; Saeki T; Takagami S; Kirihara Y; Jinushi K; Nishiyama M; Niimoto M; Hattori T; Okada K
Prediction of the resistance of human tumors to adriamycin by chemosensitivity tests and DNA analysis of the multidrug resistance gene.
The Japanese journal of surgery 1990;20(2):192-6.
-
1990: Niimoto M; Saeki T; Toi M; Nishiyama M; Hirai T; Yanagawa E; Hattori T
Prospective randomized controlled study on bestatin in resectable gastric cancer--third report.
The Japanese journal of surgery 1990;20(2):186-91.
-
1989: Nishiyama M; Kim R; Jinushi K; Takagami S; Kirihara Y; Toge T
Antitumor effect of KW2149, a new mitomycin derivative, administered by different modalities.
In vivo (Athens, Greece) 1989;3(6):375-9.
-
1989: Yanagawa E; Nishiyama M; Saeki T; Kim R; Jinushi K; Kirihara Y; Takagami S; Niimoto M; Hattori T
Chemosensitivity tests in colorectal cancer patients.
The Japanese journal of surgery 1989;19(4):432-8.
-
1989: Nishiyama M; Hirono M; Takagami S; Kim R; Saeki T; Kirihara Y; Jinushi K; Yanagawa E; Toge T; Niimoto M
The histological assessment and evaluation of a 4 day subrenal capsule assay by the percentage inhibition of DNA/protein.
The Japanese journal of surgery 1989;19(4):403-9.
-
1989: Takagami S; Nishiyama M; Kim R; Kirihara Y; Jinushi K; Saeki K; Saeki T; Nosoh Y; Niimoto M; Hattori T
[Comparative study on the anticancer activities of KW2149 and mitomycin C against human tumor xenografts using subrenal capsule assay]
Gan to kagaku ryoho. Cancer & chemotherapy 1989;16(6):2189-93.
-
1989: Saeki T; Jinushi K; Kim R; Kirihara Y; Takagami S; Nishiyama M; Saeki K; Niimoto M; Hattori T
[Comparison of succinic dehydrogenase inhibition test with adenosine triphosphate inhibition assay for human solid tumors as in vitro chemosensitivity tests]
Gan to kagaku ryoho. Cancer & chemotherapy 1989;16(5):2025-30.
-
1988: Nishiyama M; Takagami S; Kim R; Kirihara Y; Saeki T; Jinushi K; Niimoto M; Hattori T
[Inhibition of thymidylate synthetase and antiproliferative effect by 1-hexylcarbamoyl-5-fluorouracil]
Gan to kagaku ryoho. Cancer & chemotherapy 1988;15(11):3109-13.
-
1988: Nishiyama M; Kim R; Saeki T; Takagami S; Kirihara Y; Jinushi K; Toge T; Niimoto M; Hattori T
[Anticancer activities of a new mitomycin derivative KW 2149, against human tumors xenografted into nude mice]
Gan to kagaku ryoho. Cancer & chemotherapy 1988;15(11):3133-7.
-
1988: Nishiyama M; Takagami S; Kirihara Y; Saeki T; Niimi K; Nosoh Y; Hirabayashi N; Niimoto M; Hattori T
The indications of chemosensitivity tests against various anticancer agents.
The Japanese journal of surgery 1988;18(6):647-52.
-
1988: Nishiyama M; Takagami S; Kirihara Y; Saeki T; Hirabayashi N; Nosoh Y; Niimoto M; Hattori T
The antiproliferative effects of fluoropyrimidine derivatives against human tumor xenografts in a subrenal capsule assay.
The Japanese journal of surgery 1988;18(6):725-8.
-
1988: Nishiyama M; Takagami S; Kirihara Y; Saeki T; Niimi K; Kim R; Jinushi K; Toge T; Niimoto M; Hattori T
[Combined effects of interferon alpha-A/D with fluoropyrimidine derivatives in the subrenal capsule assay]
Gan to kagaku ryoho. Cancer & chemotherapy 1988;15(8):2285-90.
-
1988: Saeki T; Kuninobu H; Kodama H; Nishiyama M; Yoshinaka K; Toge T; Niimoto M; Hattori T
[Multidisciplinary treatment of unresectable liver cancer]
Gan to kagaku ryoho. Cancer & chemotherapy 1988;15(8 Pt 2):2583-9.
-
1988: Yoshinaka K; Tanaka T; Takagami S; Saeki T; Nishiyama M; Toge T; Niimoto M; Hattori T
[Prospective randomized controlled study of bestatin in gastric cancer surgery]
Gan to kagaku ryoho. Cancer & chemotherapy 1988;15(3):493-8.
-
1988: Nishiyama M; Niimi K; Takagami S; Hirabayashi N; Yamaguchi M; Saeki T; Yoshinaka K; Wang D C; Niimoto M; Hattori T
Combined effects of UFT with other anticancer agents using in vivo chemosensitivity tests.
The Japanese journal of surgery 1988;18(1):93-7.
-
1987: Noso Y; Niimi K; Nishiyama M; Hirabayashi N; Toge T; Niimoto M; Hattori T
Clinical studies on a new screening assay for anticancer agents using nude mice and isotopic evaluation.
Cancer research 1987;47(23):6418-22.
-
1987: Hirabayashi N; Nishiyama M; Niimi K; Yamaguchi M; Toge T; Niimoto M; Hattori T
Effect of oxygen tension on the antitumor activity of mitomycin C assayed by human tumor clonogenic assay.
The Japanese journal of surgery 1987;17(5):402-6.
-
1987: Niimoto M; Nishiyama M; Takagami S; Niimi K; Saeki T; Yoshinaka K; Hattori T
[Clinical trials of the subrenal capsule assay]
Gan to kagaku ryoho. Cancer & chemotherapy 1987;14(8):2444-9.
-
1987: Nosoh Y; Toge T; Niimi K; Nishiyama M; Hirabayashi N; Nakanishi K; Niimoto M; Hattori T
Experimental studies on the combined effects of alpha and gamma interferons against human tumor xenografts transplanted into nude mice.
The Japanese journal of surgery 1987;17(3):168-73.
-
1987: Niimi K; Nishiyama M; Hirabayashi N; Yamaguchi M; Nosoh Y; Wang D C; Toge T; Niimoto M; Hattori T
[In vivo chemosensitivity test for UFT and FT-207. II. Chemosensitivity test on human tumor xenografts transplanted in nude mice]
Gan to kagaku ryoho. Cancer & chemotherapy 1987;14(5 Pt 1):1281-5.
-
1987: Nosoh Y; Nishiyama M; Niimi K; Hirabayashi N; Toge T; Niimoto M; Hattori T
Antitumor activities of KW-2152, a new isoquinon agent, against human tumor xenografts transplanted into nude mice.
The Japanese journal of surgery 1987;17(2):146-9.
-
1987: Hirabayashi N; Noso Y; Niimi K; Nishiyama M; Yamaguchi M; Toge T; Niimoto M; Hattori T
Comparative studies on in vitro human tumor clonogenic assay (HTCA) and in vivo nude mouse-isotope assay (NM-IA).
The Japanese journal of surgery 1987;17(2):104-9.
-
1987: Nishiyama M; Niimi K; Yamaguchi M; Hirabayashi N; Nosoh Y; Tohge T; Niimoto M; Hattori T
[In vivo chemosensitivity test for UFT and FT-207. I--Subrenal capsule assay]
Gan to kagaku ryoho. Cancer & chemotherapy 1987;14(1):109-13.
-
1986: Nishiyama M; Noso Y; Hirabayashi N; Yamaguchi M; Toge T; Niimoto M; Hattori T
Prediction of individual tumor chemosensitivity in subrenal capsule assay.
The Japanese journal of surgery 1986;16(4):257-61.
-
1986: Nishiyama M; Noso Y; Yamaguchi M; Hirabayashi N; Toge T; Niimoto M; Hattori T
[Sensitivity test of anticancer agents by subrenal capsule assay (SRC assay). II--Determination of tumor sensitivity by percentage inhibition of DNA protein]
Gan to kagaku ryoho. Cancer & chemotherapy 1986;13(2):275-9.
Sign-in to see more
